ROCM Stock Analysis

A reader wrote in with this analysis on ROCM, Rochester Medical Corp.

1) “ROCM has a float of only 7.6 million shares. Volume has been increasing to the upside during the last few days.

2) 1) It is the highest (#1) rated Medical stock by Investor’s Business Daily. It is also currently ranked #19 on IBD’s Top 100 list.

2) It has a “fair value” of $32 given to it by Vector Vest and is rated in the top five overall “under $20” stocks by Vector Vest.
3) The stock charts on ROCM are “extremely bullish”. The MACD and Stochastics are positive, RSI is not overbought and the stock is above the 10,20,30,50 moving avgs.

4) Institutions now own around 17% of the outstanding float, and have been increasing their positions every quarter:
You should definitely do some of your own additional due diligence, but I think that if ROCM can get over $19.50, the next near-term target should be around $22. I have started to initiate my position in ROCM over the last few days.”